Lucid Diagnostics Inc.

NASDAQ:LUCD

0.945 (USD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Revenue 2.4280.3770.5000
Cost of Revenue 8.4783.6140.585000
Gross Profit -6.05-3.237-0.085000
Gross Profit Ratio -2.492-8.586-0.17000
Reseach & Development Expenses 7.25211.4669.2965.4433.4620.716
General & Administrative Expenses 19.25423.68512.7782.8370.9590.615
Selling & Marketing Expenses 16.40416.1345.261.3050-0.205
SG&A 35.1839.81918.0382.8370.9590.41
Other Expenses -4.1661.6490000
Operating Expenses 42.43252.93427.3348.284.4211.126
Operating Income -48.482-56.171-27.419-8.28-4.421-1.126
Operating Income Ratio -19.968-148.995-54.838000
Total Other Income Expenses Net -4.1840-0.6590-0-0
Income Before Tax -52.666-56.171-28.078-8.28-4.421-1.126
Income Before Tax Ratio -21.691-148.995-56.156000
Income Tax Expense 2.3311.7080.659-8.28-4.421-1.689
Net Income -52.666-56.171-28.737-8.28-4.421-1.126
Net Income Ratio -21.691-148.995-57.474000
EPS -1.26-1.55-0.82-0.22-0.12-0.03
EPS Diluted -1.26-1.55-0.82-0.22-0.12-0.03
EBITDA -45.983-54.235-27.415-8.28-4.421-1.126
EBITDA Ratio -18.939-143.859-54.83000